1
|
Coleman P, de Lecea L, Gotter A, Hagan J, Hoyer D, Kilduff T, Kukkonen JP, Porter R, Renger J, Siegel JM, Sutcliffe G, Upton N, Winrow CJ. Orexin receptors in GtoPdb v.2021.3. IUPHAR BPS Guide Pharm CITE 2021; 2021. [PMID: 34927075 DOI: 10.2218/gtopdb/f51/2021.3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Orexin receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Orexin receptors [42]) are activated by the endogenous polypeptides orexin-A and orexin-B (also known as hypocretin-1 and -2; 33 and 28 aa) derived from a common precursor, preproorexin or orexin precursor, by proteolytic cleavage and some typical peptide modifications [109]. Currently the only orexin receptor ligands in clinical use are suvorexant and lemborexant, which are used as hypnotics. Orexin receptor crystal structures have been solved [134, 133, 54, 117, 46].
Collapse
|
2
|
Schubert JW, Harrison ST, Mulhearn J, Gomez R, Tynebor R, Jones K, Bunda J, Hanney B, Wai JM, Cox C, McCauley JA, Sanders JM, Magliaro B, O'Brien J, Pajkovic N, Huszar Agrapides SL, Taylor A, Gotter A, Smith SM, Uslaner J, Browne S, Risso S, Egbertson M. Discovery, Optimization, and Biological Characterization of 2,3,6‐Trisubstituted Pyridine‐Containing M
4
Positive Allosteric Modulators. ChemMedChem 2019; 14:943-951. [PMID: 30920765 DOI: 10.1002/cmdc.201900088] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Indexed: 11/08/2022]
Affiliation(s)
| | - Scott T. Harrison
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - James Mulhearn
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - Robert Gomez
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - Robert Tynebor
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - Kristen Jones
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - Jaime Bunda
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - Barbara Hanney
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | | | - Chris Cox
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - John A. McCauley
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| | - John M. Sanders
- Department of Computational and Structural ChemistryMerck & Co., Inc. West Point PA USA
| | - Brian Magliaro
- Department of In Vitro PharmacologyMerck & Co., Inc. West Point PA USA
| | - Julie O'Brien
- Department of In Vitro PharmacologyMerck & Co., Inc. West Point PA USA
| | - Natasa Pajkovic
- Department of Pharmacokinetics, Pharmacodynamics, and Drug MetabolismMerck & Co., Inc West Point PA USA
| | | | - Anne Taylor
- Department of In Vivo PharmacologyMerck & Co., Inc. West Point PA USA
| | - Anthony Gotter
- Department of Neuroscience ResearchMerck & Co., Inc. West Point PA USA
| | - Sean M. Smith
- Department of Neuroscience ResearchMerck & Co., Inc. West Point PA USA
| | - Jason Uslaner
- Department of Neuroscience ResearchMerck & Co., Inc. West Point PA USA
| | - Susan Browne
- Department of In Vivo PharmacologyMerck & Co., Inc. West Point PA USA
| | - Stefania Risso
- Department of Neuroscience ResearchMerck & Co., Inc. West Point PA USA
| | - Melissa Egbertson
- Department of Medicinal ChemistryMerck & Co., Inc. West Point PA USA
| |
Collapse
|
3
|
Scarpa JR, Jiang P, Gao VD, Fitzpatrick K, Millstein J, Olker C, Gotter A, Winrow CJ, Renger JJ, Kasarskis A, Turek FW, Vitaterna MH. Cross-species systems analysis identifies gene networks differentially altered by sleep loss and depression. Sci Adv 2018; 4:eaat1294. [PMID: 30050989 PMCID: PMC6059761 DOI: 10.1126/sciadv.aat1294] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Accepted: 06/18/2018] [Indexed: 06/08/2023]
Abstract
To understand the transcriptomic organization underlying sleep and affective function, we studied a population of (C57BL/6J × 129S1/SvImJ) F2 mice by measuring 283 affective and sleep phenotypes and profiling gene expression across four brain regions. We identified converging molecular bases for sleep and affective phenotypes at both the single-gene and gene-network levels. Using publicly available transcriptomic datasets collected from sleep-deprived mice and patients with major depressive disorder (MDD), we identified three cortical gene networks altered by the sleep/wake state and depression. The network-level actions of sleep loss and depression were opposite to each other, providing a mechanistic basis for the sleep disruptions commonly observed in depression, as well as the reported acute antidepressant effects of sleep deprivation. We highlight one particular network composed of circadian rhythm regulators and neuronal activity-dependent immediate-early genes. The key upstream driver of this network, Arc, may act as a nexus linking sleep and depression. Our data provide mechanistic insights into the role of sleep in affective function and MDD.
Collapse
Affiliation(s)
- Joseph R. Scarpa
- Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Peng Jiang
- Center for Sleep and Circadian Biology, Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA
| | - Vance D. Gao
- Center for Sleep and Circadian Biology, Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA
| | - Karrie Fitzpatrick
- Center for Sleep and Circadian Biology, Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA
| | | | - Christopher Olker
- Center for Sleep and Circadian Biology, Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA
| | - Anthony Gotter
- Department of Neuroscience, Merck Research Laboratories, West Point, PA 19486, USA
| | | | - John J. Renger
- Department of Neuroscience, Merck Research Laboratories, West Point, PA 19486, USA
| | - Andrew Kasarskis
- Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Fred W. Turek
- Center for Sleep and Circadian Biology, Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA
| | - Martha H. Vitaterna
- Center for Sleep and Circadian Biology, Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA
| |
Collapse
|
4
|
Jiang P, Scarpa JR, Gao VD, Fitzpatrick K, Gotter A, Winrow CJ, Renger JJ, Vitaterna MH, Kasarskis A, Turek FW. 0018 DATA MINING OF MULTIPLE GENOMICS DATASETS UNCOVERS CONVERGENT GENE NETWORKS INTEGRATING CIRCADIAN TIMING AND HOMEOSTATIC DRIVE FOR SLEEP REGULATION. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|